These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11838107)

  • 21. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Gastric ulcer and duodenal ulcer (excluding Zollinger-Ellison syndrome). Epidemiology, physiopathology, diagnosis, course, treatment].
    Bigard MA
    Rev Prat; 1999 Mar; 49(5):547-54. PubMed ID: 10358406
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical effectiveness of ciprofloxacin in a female patient with peptic ulcer associated with Helicobacter infection].
    Il'chenko AA; Korshunov VM; Gorodinskaia VS
    Klin Med (Mosk); 1995; 73(6):64-5. PubMed ID: 8691796
    [No Abstract]   [Full Text] [Related]  

  • 24. [The outline of medical treatment of peptic ulcer].
    Nakamura T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():365-70. PubMed ID: 11979808
    [No Abstract]   [Full Text] [Related]  

  • 25. Famotidine to prevent peptic ulcer caused by NSAIDs.
    Singh G; Fries JF
    N Engl J Med; 1996 Oct; 335(17):1322; author reply 1322-3. PubMed ID: 8992334
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
    Carrère MO; Auquier P; Poynard T; Sambuc R
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1023-30. PubMed ID: 8729415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastric ulcer].
    Kanke K; Hiraishi H; Terano A
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():144-50. PubMed ID: 11838106
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F; Smith AC; Stokes PL
    N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract]   [Full Text] [Related]  

  • 31. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH; Salena BJ; Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
    Lamouliatte H
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S58-S63. PubMed ID: 8734372
    [No Abstract]   [Full Text] [Related]  

  • 34. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Duodenal ulcer: the current etiopathogenic concepts, acid hypersecretion? Helicobacter pylori? nonsteroidal anti-inflammatory drugs?].
    Katz J; Corti RE; López Gastón A
    Acta Gastroenterol Latinoam; 1992; 22(4):263-4. PubMed ID: 1340682
    [No Abstract]   [Full Text] [Related]  

  • 38. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
    Rollan A; Giancaspero R; Fuster F; Acevedo C; Figueroa C; Hola K; Schulz M; Duarte I
    Am J Gastroenterol; 2000 Jan; 95(1):50-6. PubMed ID: 10638558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
    Pohle T; Hilker E; Domschke W
    Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.